596 related articles for article (PubMed ID: 22777220)
1. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.
Celik A; Tiryaki S; Musayev A; Kismali E; Levent E; Ergun O
J Drugs Dermatol; 2012 Jul; 11(7):808-11. PubMed ID: 22777220
[TBL] [Abstract][Full Text] [Related]
2. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results of propranolol treatment for patients with infantile hemangioma.
Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
[TBL] [Abstract][Full Text] [Related]
4. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
[TBL] [Abstract][Full Text] [Related]
5. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
6. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
[TBL] [Abstract][Full Text] [Related]
7. Successful discontinuation of propranolol for infantile hemangiomas of the head and neck at 12 months of age.
Hong P; Tammareddi N; Walvekar R; Chiu ES; Poole JC; Kluka EA; Simon LM
Int J Pediatr Otorhinolaryngol; 2013 Jul; 77(7):1194-7. PubMed ID: 23706952
[TBL] [Abstract][Full Text] [Related]
8. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma.
Denoyelle F; Leboulanger N; Enjolras O; Harris R; Roger G; Garabedian EN
Int J Pediatr Otorhinolaryngol; 2009 Aug; 73(8):1168-72. PubMed ID: 19481268
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.
Thoumazet F; Léauté-Labrèze C; Colin J; Mortemousque B
Br J Ophthalmol; 2012 Mar; 96(3):370-4. PubMed ID: 21673014
[TBL] [Abstract][Full Text] [Related]
10. Hemangiomas of the nasal tip treated with propranolol.
Ben-Amitai D; Halachmi S; Zvulunov A; Raveh E; Kalish E; Lapidoth M
Dermatology; 2012; 225(4):371-5. PubMed ID: 23428617
[TBL] [Abstract][Full Text] [Related]
11. The use of propranolol for complicated infantile hemangiomas.
Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
[TBL] [Abstract][Full Text] [Related]
12. Use of propranolol for infantile hemangiomas.
Küpeli S
Pediatr Hematol Oncol; 2012 Apr; 29(3):293-8. PubMed ID: 22303875
[TBL] [Abstract][Full Text] [Related]
13. Propranolol for treatment of ulcerated infantile hemangiomas.
Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
[TBL] [Abstract][Full Text] [Related]
14. Propranolol use for infantile hemangiomas: American Society of Pediatric Otolaryngology Vascular Anomalies Task Force practice patterns.
Parikh SR; Darrow DH; Grimmer JF; Manning SC; Richter GT; Perkins JA
JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):153-6. PubMed ID: 23429945
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].
Qin ZP; Liu XJ; Li KL; Zhou Q; Yang XJ; Zheng JW
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3130-4. PubMed ID: 20193276
[TBL] [Abstract][Full Text] [Related]
16. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
17. [News on infantile hemangioma therapy by beta-blocker].
Delmotte N; Curti C; Montana M; Crozet M; Vanelle P; Gensollen S
Therapie; 2012; 67(3):257-65. PubMed ID: 22874493
[TBL] [Abstract][Full Text] [Related]
18. Propranolol for severe infantile hemangiomas: follow-up report.
Sans V; de la Roque ED; Berge J; Grenier N; Boralevi F; Mazereeuw-Hautier J; Lipsker D; Dupuis E; Ezzedine K; Vergnes P; Taïeb A; Léauté-Labrèze C
Pediatrics; 2009 Sep; 124(3):e423-31. PubMed ID: 19706583
[TBL] [Abstract][Full Text] [Related]
19. Use of propranolol in infantile haemangioma among Chinese children.
Chik KK; Luk CK; Chan HB; Tan HY
Hong Kong Med J; 2010 Oct; 16(5):341-6. PubMed ID: 20889997
[TBL] [Abstract][Full Text] [Related]
20. In brief: oral propranolol infantile hemangiomas.
Med Lett Drugs Ther; 2011 Oct; 53(1376):88. PubMed ID: 22033213
[No Abstract] [Full Text] [Related]
[Next] [New Search]
